Nuritas Raises US$20 Million in Series A Funding Using Artificial Intelligence To Unlock Bioactive Peptides To Address Societal Issues

Spread the love

Nuritas LogoDUBLIN, Dec. 20, 2017 /PRNewswire/ — Nuritas, a biotechnology company that is revolutionizing the discovery and use of bioactive peptides through artificial intelligence (AI) and genomics, today announced the close of a US$20 million Series A funding round led by Chicago-based Cultivian…



VISIT THE SOURCE ARTICLE
Author:

No votes yet.
Please wait...
Copyright © 2018 NEURALSCULPT.COM